Table 2 Isolates from the specimen taken for microbiological proof of infection with 48 hours after enrolment
| Â | CAP N= 57 | HAP N= 57 | VAP N= 61 | Total N= 175 |
|---|---|---|---|---|
Negative | 21 (36.8%) | 21 (36.8%) | 15 (24.6%) | 57 (32.6%) |
Gram positive bacteria | 22 (38.6%) | 22 (38.6%) | 31 (50.8%) | 75 (42.9%) |
MSSA | 8 (14.0%) | 10 (17.5%) | 16 (13.9%) | 34 (11.6%) |
Streptococcus spp. | 8 (14.0%) | 4 (7.0%) | 5 (4.3%) | 17 (5.7%) |
MRSA | 4 (7.0%) | 1 (1.8%) | 0 (0%) | 5 (1.7%) |
Enterococcus spp. | 0 (0%) | 0 (0%) | 4 (6.6%) | 4 (2.3%) |
Other | 2 (3.5%) | 7 (12.3%) | 6 (9.8%) | 15 (8.6%) |
Gram negative bacteria | 22 (38.6%) | 19 (33.3%) | 22 (36.1%) | 63 (36.0%) |
Pseudomonas spp. | 5 (8.8%) | 5 (8.8%) | 6 (9.8%) | 16 (5.4%) |
E. coli | 5 (8.8%) | 3 (5.3%) | 4 (6.6%) | 12 (4.1%) |
Haemophilus spp. | 3 (5.3%) | 3 (5.3%) | 4 (6.6%) | 10 (3.4%) |
Klebsiella spp. | 2 (3.5%) | 2 (3.5%) | 2 (3.3%) | 6 (2.0%) |
Proteus spp. | 0 (0%) | 0 (0%) | 3 (4.9%) | 3 (1.7%) |
Other | 7 (12.3%) | 6 (10.5%) | 3 (4.9%) | 16 (9.1%) |
Yeasts | 4 (7.0%) | 9 (15.8%) | 8 (13.1%) | 21 (12.0%) |